Published in Heart Disease Weekly, December 15th, 2002
Researchers compared the effects of nitric oxide-containing aspirin (NO-aspirin, NCX-4016), regular aspirin, and placebo on atherosclerosis development in hypercholesterolemic low-density lipoprotein (LDL)-receptor-deficient mice.
"Male mice were assigned randomly to receive in a volume of 10 ml/kg either placebo (n=10), 30 mg/kg/day NO-aspirin (n=10), or 18 mg/kg/day of regular aspirin (n=10)," explained C. Napoli and colleagues, University of Naples Federico II, Italy.
The researchers reported that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.